On June 16, 2026, the 24th CPHI China and 19th PMEC China officially opened at the Shanghai New International Expo Center, bringing together pharmaceutical professionals from around the world for business collaboration, technology exchange, and industry networking. As the biopharmaceutical sector enters a new phase of innovation and transformation, the event provided fresh momentum for industry growth and development.
Guided by deep industry expertise and a forward-looking strategy, Morimatsu and its brands continue to anticipate evolving market trends and customer needs. Through a dual focus on technology and R&D, the company has built a product portfolio designed to support the next generation of pharmaceutical manufacturing.
1.New Upstream Process Platform for Laboratories
Five newly launched products from Bioengineering were showcased at the exhibition, including the Taberis Xpert, Taberis Prime, and Taberis Parasmart benchtop bioreactors, as well as the Bagento and Ondalis single-use bioreactors. Making their exhibition debut, the systems attracted significant attention from industry professionals and visitors.
To highlight the value and capabilities of the new portfolio, senior product experts from Bioengineering delivered detailed presentations at the booth. Through live demonstrations and real-world application examples, they showed how the product lineup creates a comprehensive bioprocessing platform that supports every stage of biomanufacturing—from laboratory research and process development to pilot-scale operations and production—helping organizations move from isolated laboratory workflows toward fully integrated process management. Their insights brought the precision and innovation of Swiss engineering to life for attendees.
2.Solid Preparation Process Solution
The Multi-functional Fluidized Bed is equipped with easily interchangeable product pot modules, enabling multifunctional granulation, drying, and coating operations on a single machine. This ensures flexibility for product development and process improvement. The Wet Granulator with smooth speed control provides precise parameters for operation; the switchable product pot module may meet your needs for different throughputs in experiments.
3.API Process Solution
The Multi-functional Filter-Dryer integrates filtration, washing, and drying within a single unit, streamlining processes with full automation to boost efficiency and prevent contamination. The spray dryer features a highly integrated modular design that ensures seamless process transfer from experimental trials to batch production by maintaining consistent process parameters, facilitating smooth and efficient scale-up.
4.Total Formulation Solution
MoriSora Technology’s lyophilization production line, with the core concept of integrating functional units, organically integrates modules such as lyophilizers, in-feed and out-feed systems, Grade A environmental barrier systems, and filling systems. It achieves three major technological breakthroughs: flexible adaptability, high efficiency and energy saving, as well as intelligent control. It also provides dual-engine support of "equipment + services.
Taking advantage of the exhibition platform, Morimatsu actively engaged with partners across the pharmaceutical value chain, participating in meaningful discussions on emerging technologies, industry trends, and new drivers of growth. These exchanges provided valuable opportunities to explore collaboration, share insights, and identify areas of mutual development. At the same time, through ongoing market analysis and close engagement with customers, Morimatsu continued to uncover new opportunities for strategic growth and business expansion.
As the pharmaceutical industry continues to globalize, innovative medicines and biopharmaceuticals are emerging as key drivers of international growth. Morimatsu is accelerating its global expansion strategy, leveraging innovative and efficient solutions to capture new opportunities worldwide while contributing to better health outcomes around the globe.
About Morimatsu LifeSciences
Morimatsu LifeSciences is a key business segment of Morimatsu International Holdings Limited (Stock Code: 2155.HK). It comprises Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) LifeSciences Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Shanghai Mori-Biounion Technology Co., Ltd., Shanghai Morisora Technology Co., Ltd., Bioengineering AG, Pharmadule Morimatsu AB, and its affiliated companies.
Morimatsu LifeSciences is dedicated in providing core equipment, process systems, and smart modular facility solutions, and services for the pharmaceutical, biopharmaceutical, medical aesthetics, and fast-moving consumer goods (FMCG) sectors including (cosmetics, food, and health supplements), as well as data centers.
Our team comprises highly experienced professionals with deep expertise in process R&D, engineering design, advanced manufacturing, compliance and validation consulting, production execution, and intelligent operations. With broad experience across diverse industries, we fully understand the unique characteristics and process requirements of various products. This enables us to deliver tailored, end-to-end process solutions from the conceptual design stage, precisely aligned with client’s specific needs.
Morimatsu LifeSciences has established a strong global presence, supported by advanced R&D centers, design hubs, and state-of-the-art manufacturing facilities worldwide. Our well-established service network spans Europe,USA,Asia-Pacific, and emerging markets. We have successfully delivered outstanding, customized solutions to clients in over 40 countries and regions, gaining extensive experience in international project execution.
As a multinational enterprise with core strengths in process technology, modular facility construction, and intelligent manufacturing, Morimatsu LifeSciences is dedicated to meeting the evolving equipment and system needs of our key industries. Through continuous innovation and technological advancement, we are steadily expanding our global footprint, driving our international strategy forward, and delivering Morimatsu’s expertise, reliability, and innovation to the global life sciences and related sectors.
